Cargando…
Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma
Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, is a first-line treatment for metastatic renal cell carcinoma (mRCC) in patients in ‘low’ and ‘intermediate’ Memorial Sloan Kettering Cancer Center and Heng risk groups. Disruptions of hematopoiesis, such as anemia, neutropenia, and thr...
Autores principales: | Kucharz, Jakub, Giza, Agnieszka, Dumnicka, Paulina, Kuzniewski, Marek, Kusnierz-Cabala, Beata, Bryniarski, Pawel, Herman, Roma, Zygulska, Aneta Lidia, Krzemieniecki, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005381/ https://www.ncbi.nlm.nih.gov/pubmed/27573381 http://dx.doi.org/10.1007/s12032-016-0818-9 |
Ejemplares similares
-
Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients
por: Buda-Nowak, Anna, et al.
Publicado: (2017) -
Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients
por: Żyłka, Agnieszka, et al.
Publicado: (2018) -
Sterile leukocyturia affects urine neutrophil gelatinase-associated lipocalin concentration in type 2 diabetic patients
por: Gala-Błądzińska, Agnieszka, et al.
Publicado: (2016) -
Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes
por: Żyłka, Agnieszka, et al.
Publicado: (2016) -
Urinary Neutrophil Gelatinase-Associated Lipocalin Is Complementary to Albuminuria in Diagnosis of Early-Stage Diabetic Kidney Disease in Type 2 Diabetes
por: Gala-Błądzińska, Agnieszka, et al.
Publicado: (2017)